Formulation of LDL Targeted Nanostructured Lipid Carriers Loaded with Paclitaxel: A Detailed Study of Preparation, Freeze Drying Condition, and In Vitro Cytotoxicity
Figure 2
In vitro release profile of paclitaxel from cholesterol NLCs (): (a) drug/lipid 5% w/w, (b) drug/lipid 10% w/w.
